These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20455215)

  • 1. MASPECTRAS 2: An integration and analysis platform for proteomic data.
    Ubaida Mohien C; Hartler J; Breitwieser F; Rix U; Remsing Rix L; Winter GE; Thallinger GG; Bennett KL; Superti-Furga G; Trajanoski Z; Colinge J
    Proteomics; 2010 Jul; 10(14):2719-22. PubMed ID: 20455215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.
    Remsing Rix LL; Rix U; Colinge J; Hantschel O; Bennett KL; Stranzl T; Müller A; Baumgartner C; Valent P; Augustin M; Till JH; Superti-Furga G
    Leukemia; 2009 Mar; 23(3):477-85. PubMed ID: 19039322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MASPECTRAS: a platform for management and analysis of proteomics LC-MS/MS data.
    Hartler J; Thallinger GG; Stocker G; Sturn A; Burkard TR; Körner E; Rader R; Schmidt A; Mechtler K; Trajanoski Z
    BMC Bioinformatics; 2007 Jun; 8():197. PubMed ID: 17567892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRIDEViewer: a novel user-friendly interface to visualize PRIDE XML files.
    Medina-Aunon JA; Carazo JM; Albar JP
    Proteomics; 2011 Jan; 11(2):334-7. PubMed ID: 21204261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRIDE: a public repository of protein and peptide identifications for the proteomics community.
    Jones P; Côté RG; Martens L; Quinn AF; Taylor CF; Derache W; Hermjakob H; Apweiler R
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D659-63. PubMed ID: 16381953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells.
    Puttini M; Coluccia AM; Boschelli F; Cleris L; Marchesi E; Donella-Deana A; Ahmed S; Redaelli S; Piazza R; Magistroni V; Andreoni F; Scapozza L; Formelli F; Gambacorti-Passerini C
    Cancer Res; 2006 Dec; 66(23):11314-22. PubMed ID: 17114238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Submitting proteomics data to PRIDE using PRIDE Converter.
    Barsnes H; Vizcaíno JA; Reisinger F; Eidhammer I; Martens L
    Methods Mol Biol; 2011; 694():237-53. PubMed ID: 21082439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and dissemination of MS proteomic data with PROTICdb: example of a quantitative comparison between methods of protein extraction.
    Langella O; Valot B; Jacob D; Balliau T; Flores R; Hoogland C; Joets J; Zivy M
    Proteomics; 2013 May; 13(9):1457-66. PubMed ID: 23468041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proteios software environment: an extensible multiuser platform for management and analysis of proteomics data.
    Häkkinen J; Vincic G; Månsson O; Wårell K; Levander F
    J Proteome Res; 2009 Jun; 8(6):3037-43. PubMed ID: 19354269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the PRIDE proteomics identifications database for knowledge discovery and data analysis.
    Jones P; Martens L
    Methods Mol Biol; 2010; 604():297-307. PubMed ID: 20013379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PRIDE proteomics identifications database: data submission, query, and dataset comparison.
    Jones P; Côté R
    Methods Mol Biol; 2008; 484():287-303. PubMed ID: 18592187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Software pipeline and data analysis for MS/MS proteomics: the trans-proteomic pipeline.
    Keller A; Shteynberg D
    Methods Mol Biol; 2011; 694():169-89. PubMed ID: 21082435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ProteomeCommons.org IO Framework: reading and writing multiple proteomics data formats.
    Falkner JA; Falkner JW; Andrews PC
    Bioinformatics; 2007 Jan; 23(2):262-3. PubMed ID: 17121776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative proteomics using uniform (15)N-labeling, MASCOT, and the trans-proteomic pipeline.
    Palmblad M; Bindschedler LV; Cramer R
    Proteomics; 2007 Oct; 7(19):3462-9. PubMed ID: 17726679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysing proteomics identifications in the context of functional and structural protein annotation: integrating annotation using PICR, DAS, and BioMart.
    Jones P
    Methods Mol Biol; 2011; 696():107-21. PubMed ID: 21063944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Information management for proteomics: a perspective.
    Wilkins MR; Arthur JW; Junius FK; Harrison MJ; Traini MD; Bizannes P; Doggett PE; McDonald W
    Expert Rev Proteomics; 2008 Oct; 5(5):663-78. PubMed ID: 18937557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IndexToolkit: an open source toolbox to index protein databases for high-throughput proteomics.
    Li D; Gao W; Ling CX; Wang X; Sun R; He S
    Bioinformatics; 2006 Oct; 22(20):2572-3. PubMed ID: 16945944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TOPPView: an open-source viewer for mass spectrometry data.
    Sturm M; Kohlbacher O
    J Proteome Res; 2009 Jul; 8(7):3760-3. PubMed ID: 19425593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SearchGUI: An open-source graphical user interface for simultaneous OMSSA and X!Tandem searches.
    Vaudel M; Barsnes H; Berven FS; Sickmann A; Martens L
    Proteomics; 2011 Mar; 11(5):996-9. PubMed ID: 21337703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel dual Src/Abl inhibitors for hematologic and solid malignancies.
    Schenone S; Brullo C; Musumeci F; Botta M
    Expert Opin Investig Drugs; 2010 Aug; 19(8):931-45. PubMed ID: 20557276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.